Nantahala Capital Management, LLC Avenue Therapeutics, Inc. Transaction History

Nantahala Capital Management, LLC

  • $1.5 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$0.22 - $0.96 $319,696 - $1.4 Million
-1,453,166 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$0.88 - $1.78 $1.25 Million - $2.53 Million
1,422,955 Added 4710.06%
1,453,166 $1.32 Million
Q4 2020

Feb 16, 2021
BUY
$2.95 - $11.04 $89,122 - $333,529
30,211 New
30,211 $180,000

About AVENUE THERAPEUTICS, INC.

ATXI Quotes by TradingView
  • Ticker ATXI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 4,127,720
  • Market Cap $9.25M
  • Description
  • Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was in...
More about ATXI
Track This Portfolio

Track Nantahala Capital Management, LLC Portfolio

Follow Nantahala Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nantahala Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email